Nitric oxide and eNOS gene in essential hypertension

International Journal of Collaborative Research on Internal Medicine and Public Health

Volumn 1, Issue 2, 2009, Pages 56-71

  Arora, Shubhangi ^a   Das, Nibhriti ^a   Srivastava, Kamna ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

eNOS gene intron 4a b polymorphism; Essential hypertension; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRITE;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INTRON; MALE;

EID: 77953414422     PISSN: None     EISSN: 18404529     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Afrasyap, L., Ozturk, G. (2004). NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population. Acta Biochemica Biophisica Sinica, 36(10), 661-666.
2. Das, S. K., Sanyal, K., & Basu, A. (2005). Study of urban community survey in India: Growing trend of high prevalence of hypertension in a developing country. International Journal of Medical Sciences, 2, 70-78.
3. Ding, A. H., Nathan, C. F., & Stuehr, D. J. (1998). Release of reactive nitrogen and reactive oxygen intermediates from mouse peritoneal macrophages. Journal of Immunology, 141, 2407-2412.
4. Dosenko, V. E., Zagoriy, V. Y., Haytovich, N. V., Gordok, O. A., & Moibenko, A. A. (2006). Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochemica Polonica, 53(1), 299-302.
5. Ferlito, S., Gallina, M., Pitari, G. M., & Bianchi, A. (1998). Nitric oxide plasma levels in patients with chronic and acute cerebrovascular disorders. Panminerva medica, 40(1), 51-54.
6. Gouni-Berthold, I., Giannakidou, E., Müller-Wieland, D., Faust, M., Kotzka, J., Berthold, H. K., & Krone, W. (2005). Peroxisome proliferator-activated receptor-[gamma]2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2. Journal of Hypertension, 23, 301-308.
7. Hingorani, A. D. (2003). Endothelial nitric oxide synthase polymorphisms and hypertension. Current Hypertension Reports, 5(1), 19-25.
8. Jeerooburkhan, N., Jones, L. C.; Bujac, S., Cooper, J. A., Miller, G. J., Vallance, P., Humphries, S. E., & Hingorani, A. D. (2001). Genetic and environmental determinants of plasma nitric oxides and risk of ischemic heart disease. Hypertension, 38, 1054-1061.
9. Kato, N., Sugiyama, T., Morita, H., Nabika, T., Kurihara, H., Yamori, Y., & Yazaki, Y. (1999). Lack of evidence for association between the eNOS gene and hypertension. Hypertension, 33, 933-936.
10. Katzung, B. G. (2004). Basic & Clinical Pharmacology, 9th edition, Singapore: McGraw- Hill Lange, pp 313-318.
11. Klahr, S. (2001). The role of nitric oxide in hypertension and renal disease progression. Nephrology, Dialysis, Transplantation, 1 (16), 60-62.
12. Kumar, C. A., & Das, U. N. (2000). Lipid peroxides, antioxidants and nitric oxides in patients with pre-eclampsia and essential hypertension. Medical Science Monitor, 6, 901-907.
13. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res; 16:1215.
14. Miyamoto, Y., Saito, Y., Kajiyama, N., Yoshimura, M., Shimasaki, Y., Nakayama, M., Kamitani, S., Harada, M., Ishikawa, M., Kuwahara, K., Ogawa, E., Hamanaka, I., Takahashi, N., Kaneshige, T., Teraoka, H., Akamizu, T., Azuma, N., Yoshimasa, Y., Yoshimasa, T., Itoh, H., Masuda, I., & Yasue, H. (1998). Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension, 32, 3-8.
15. Node, K., Kitakaze, M., Yoshikawa, H., Kosaka, H., & Hori, M. (1997). Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension, 30, 405-408.
16. Rodríguez-Esparragón, F. J., Rodríguez-Pérez, J. C., Macías-Reyes, A., & Alamo-Santana, F. (2003). Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are associated with essential hypertension. Journal of Hypertension, 21, 1649-1655.
17. Srivastava K, Narang R, Sreenivas V, Das S and Das N (2008), Association of eNOS Glu298Asp gene polymorphism with essential hypertension in Asian Indians, Clin Clin Chim Acta, 387, 80-83.
18. Wang, X. L., Sim, A. S., Badenhop, R. F., McCredie, R. M., & Wilcken, D. E. (1996). A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Medicine, 2(1), 41-45.
19. Zhao, Q., Su, S-Y, Chen, S-F, Li, B., & Gu, D-F. (2006). Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chinese Medical Journal, 119(13), 1065-1071.